Wesley G. Cochrane

Scripps Research Institute

Papers

2

Total Citations

99

H-Index

2

About

Wesley G. Cochrane is a leading innovator at the intersection of chemical biology and microfluidics, whose work is redefining high-throughput screening for drug discovery. His primary research focuses on developing automated platforms that miniaturize and accelerate the identification of bioactive compounds. Cochrane’s most impactful contribution, the 2019 paper “Activity-Based DNA-Encoded Library Screening” (85 citations), pioneers a powerful hybrid approach that combines the functional readout of traditional high-throughput screening with the immense scale of DNA-encoded libraries (DELs). This method allows researchers to probe complex biological targets in an activity-based manner, overcoming a key limitation of conventional DEL technology. Complementing this, his 2017 work on the “Integrated, Continuous Emulsion Creamer” (14 citations) introduces a droplet microfluidic processor designed to replace expensive, bulky robotics with a compact, continuous-flow system for automated sample handling. By integrating these advances, Cochrane is driving a paradigm shift toward more accessible, efficient, and miniaturized screening platforms, making him a pivotal figure in the next generation of chemical probe and therapeutic discovery.

Research Focus

Key Achievements

2
H-Index
2
Papers
99
Total Citations
50
Avg Citations/Paper
🏆 Most Cited Paper
Activity-Based DNA-Encoded Library Screening
85 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Scripps Research Institute

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago